基于年龄的心脏再移植资格阈值评估——器官共享联合网络数据库分析
该研究基于器官共享联合网络数据库2003至2020年间1026例成人孤立心脏再移植患者,比较年龄>60岁(n=177)与≤60岁(n=849)受者的结局。校正后,年龄>60岁与5年死亡率(HR 1.42,95%CI 1.02-2.01,p=0.04)和10年死亡率(HR 1.72,95%CI 1.20-2.45,p=0.003)风险升高相关。作者认为年龄>60岁受者心脏再移植结局较差,需要严格的患者选择和密切随访。
要点
- 年龄>60岁受者再移植后5年死亡率风险升高(HR 1.42,95%CI 1.02-2.01,p=0.04)。
- 年龄>60岁受者10年死亡率风险升高(HR 1.72,95%CI 1.20-2.45,p=0.003)。
- 年龄>60岁受者术后卒中(6.8% vs 2.6%,p=0.01)和出院前透析需求(20.3% vs 13.2%)更高。
核心结论
- 年龄>60岁受者心脏再移植结局较年轻受者差,作者认为需要严格的患者选择和密切随访以确保供心的合理利用并改善长期结局。
研究设计与样本
- 回顾性分析器官共享联合网络数据库2003至2020年间1026例成人孤立心脏再移植患者,年龄>60岁受者177例与≤60岁受者849例进行比较。
主要发现
- 年龄>60岁受者更常为男性、合并糖尿病或既往恶性肿瘤,基线肌酐更高。
- 年龄>60岁受者移植前需要ECMO的比例更高(11.9% vs 6.8%,p=0.02),因原发性移植物衰竭接受再移植的比例更高(13.6% vs 8.5%,p=0.03)。
- 年龄>60岁受者术后卒中发生率更高(6.8% vs 2.6%,p=0.01),出院前透析需求更高(20.3% vs 13.2%),因恶性肿瘤相关原因死亡的比例更高(16.3% vs 3.9%,p<0.001)。
- 校正后年龄>60岁与5年死亡率风险升高相关(HR 1.42,95%CI 1.02-2.01,p=0.04),与10年死亡率风险升高相关(HR 1.72,95%CI 1.20-2.45,p=0.003)。
- 限制性立方样条显示受者年龄与10年死亡率之间呈非线性关系。
关键数值与推荐
- 年龄>60岁受者移植前ECMO使用率为11.9%,≤60岁受者为6.8%(p=0.02)。
- 年龄>60岁受者因原发性移植物衰竭再移植比例为13.6%,≤60岁受者为8.5%(p=0.03)。
- 年龄>60岁受者术后卒中发生率为6.8%,≤60岁受者为2.6%(p=0.01)。
- 年龄>60岁受者出院前透析需求为20.3%,≤60岁受者为13.2%。
- 年龄>60岁受者恶性肿瘤相关死亡比例为16.3%,≤60岁受者为3.9%(p<0.001)。
临床怎么用
- 作者认为年龄>60岁受者心脏再移植结局较差,需要严格的患者选择和密切随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Risk-adjusted survival after late heart re-transplantation may be comparable to primary transplant, but the efficacy of re-transplantation in older candidates is not established. We evaluated outcomes after heart re-transplantation in recipients > 60 years. METHODS: We identified 1026 adult patients undergoing isolated heart re-transplantation between 2003 and 2020 from the United Network for Organ Sharing database. Older recipients (> 60 years, n=177) were compared to younger recipients (≤ 60 years, n=849). Five and ten-year post-transplant survival was estimated using the Kalpan-Meier method and adjusted with multivariable Cox models. RESULTS: Older recipients were more likely to be male and have diabetes or previous malignancies with higher baseline creatinine. They also more frequently required pre-transplant ECMO (11.9% vs. 6.8%, p=0.02) and received re-transplantation due to primary graft failure (13.6% vs. 8.5%, p=0.03). After the transplant, older recipients had a higher incidence of stroke (6.8% vs. 2.6%, p=0.01) and dialysis requirements (20.3% vs. 13.2%) before discharge (both p<0.05), and more frequently died from malignancy-related causes (16.3% vs. 3.9%, p<0.001). After adjustment, recipient age >60 was associated with an increased risk of both 5-year (HR 1.42, 95% CI 1.02-2.01, p=0.04) and 10-year mortality (HR 1.72, 95% CI 1.20-2.45, p=0.003). Restricted cubic spline showed a non-linear relationship between recipient age and 10-year mortality. CONCLUSIONS: Heart re-transplantation in recipients > 60 years has inferior outcomes compared to younger recipients. Strict patient selection and close follow-up are warranted to ensure the appropriate utilization of donor hearts and to improve long-term outcomes.
引用
- Chen Q, Malas J, Chan J, et al. Evaluating age-based eligibility thresholds for heart re-transplantation - an analysis of the united network for organ sharing database. J Heart Lung Transplant. 2022. PMID: 36535808. doi:10.1016/j.healun.2022.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。